"non-functional right implantable catheter arrives for application day 1 of folfoxiri scheme, under sterile technique cannulation is performed with surecam needle, no return is obtained, we proceed to infuse ssn and there is evidence of superior extravasation at the level of the catheter route and the user also reports a burning sensation.The patient reports that the catheter has not been manipulated since the beginning of this year and that the previous time in the hospital they punctured it but it became inflamed and they did not give her any indication", the patient received incomplete chemotherapy because the 5fu infuser could not be connected, so it is considered a non-serious adverse event, patient pending evaluation by general cx with thorax rx to determine catheter removal.".
|
Note: product reference 4430409 is not cleared for sales in the usa, but it is similar to a product reference cleared under #510k130576.Device history record the batch record file was reviewed: the 150 units of this batch released in november 2022 were manufactured within the specifications and no discrepancy was observed.No other similar complaint was reported on this batch of access ports.Summary of investigation no sample, pictures / videos and x-ray pictures were returned for investigation.Conclusion without the sample for evaluation and x-ray pictures, it is not possible to determine the root cause of this incident.However, the batch history record has not actually revealed failure during manufacturing process.Catheter rupture is a known complication of the access port implantation.This type of incident remains rare (0.01%).No corrective action is currently envisaged.
|